Literature DB >> 16913576

Pulmonary complications in primary hypogammaglobulinemia: a survey by high resolution CT scan.

M Gharagozlou1, F A Ebrahimi, A Farhoudi, A Aghamohammadi, M-H Bemanian, Z Chavoshzadeh, M Heidarzadeh, M Mehdizadeh, M Moin, M Movahedi, M Nabavi, Z Pourpak, N Rezaei.   

Abstract

BACKGROUND: Primary hypogammaglobulinemia disorders are a group of heterogeneous immunodeficiency syndromes with an increased susceptibility to pulmonary complications.
METHODS: The aim of this study was to evaluate the extent of lung abnormalities in primary hypogammaglobulinaemic patients by high resolution computed tomography (HRCT) scan and pulmonary function test (PFT). HRCT and PFT were performed in 22 Iranian patients with primary hypogammaglobulinemia.
RESULTS: Pathological bronchial findings were observed in thirteen patients: three patients showed only peribronchial thickening and the remaining ten patients suffered from both bronchiectasis and peribronchial wall thickening. Mild type of bronchiectasis and peribronchial wall thickening were the most common type, predominantly observed in the right middle and both right and left lower lobe segments of lungs. Although bullae were not found, emphysema, air-trapping, and collapse/consolidation were observed in two patients. Bronchial involvement was mostly limited to 1 up to 5 bronchopulmonary segments; only one HRCT indicated bronchial involvement in more than nine bronchopulmonary segments. Pathological bronchial findings mostly observed in the proximal bronchi; meanwhile the involvement of the distal bronchi was less common. Decreasing FEVI and FVC were observed in 65% and 55% of patients, respectively. There was a significant correlation between the HRCT score and the predicted values by PFT. The delay of diagnosis in patients with bronchiectasis was significantly higher than those without bronchiectasis.
CONCLUSIONS: It seems that the majority of hypogammaglobulinaemic patients suffer from the mild type of bronchiectasis, which is mostly observed in the proximal bronchi of the lower lobe segments. The delay of diagnosis plays an important role in the occurrence of this complication in these patients.

Entities:  

Mesh:

Year:  2006        PMID: 16913576     DOI: 10.4081/monaldi.2006.567

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  9 in total

1.  Airway and interstitial lung disease are distinct entities in paediatric common variable immunodeficiency.

Authors:  A A J M van de Ven; P A de Jong; D P Hoytema van Konijnenburg; O A M Kessels; M Boes; E A M Sanders; S W J Terheggen-Lagro; J M van Montfrans
Journal:  Clin Exp Immunol       Date:  2011-06-02       Impact factor: 4.330

2.  Chronic suppurative lung disease in adults.

Authors:  Mark L Metersky; Antranik Mangardich
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

3.  Respiratory Complications in Patients with Hyper IgM Syndrome.

Authors:  Bobak Moazzami; Reza Yazdani; Gholamreza Azizi; Fatemeh Kiaei; Mitra Tafakori; Mohammadreza Modaresi; Rohola Shirzadi; Seyed Alireza Mahdaviani; Mahsa Sohani; Hassan Abolhassani; Asghar Aghamohammadi
Journal:  J Clin Immunol       Date:  2019-06-11       Impact factor: 8.317

4.  History of primary immunodeficiency diseases in iran.

Authors:  Asghar Aghamohammadi; Mostafa Moin; Nima Rezaei
Journal:  Iran J Pediatr       Date:  2010-03       Impact factor: 0.364

Review 5.  Pulmonary manifestations of primary immunodeficiency disorders in children.

Authors:  Milos Jesenak; Peter Banovcin; Barbora Jesenakova; Eva Babusikova
Journal:  Front Pediatr       Date:  2014-07-25       Impact factor: 3.418

6.  The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis.

Authors:  Hamdan Al-Jahdali; Abdullah Alshimemeri; Abdullah Mobeireek; Amr S Albanna; Nehad N Al Shirawi; Siraj Wali; Khaled Alkattan; Abdulrahman A Alrajhi; Khalid Mobaireek; Hassan S Alorainy; Mohamed S Al-Hajjaj; Anne B Chang; Stefano Aliberti
Journal:  Ann Thorac Med       Date:  2017 Jul-Sep       Impact factor: 2.219

7.  Antibody deficiency in patients with frequent exacerbations of Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Brian N McCullagh; Alejandro P Comellas; Zuhair K Ballas; John D Newell; M Bridget Zimmerman; Antoine E Azar
Journal:  PLoS One       Date:  2017-02-17       Impact factor: 3.240

8.  Diagnosing and preventing chronic suppurative lung disease (CSLD) and bronchiectasis.

Authors:  A B Chang; C A Byrnes; M L Everard
Journal:  Paediatr Respir Rev       Date:  2010-12-04       Impact factor: 2.726

9.  Chest CT Manifestations in Children with CVID: A 10-Year Report.

Authors:  Mohammad Reza Boloursaz; Soheila Khalilzadeh; Pegah Rahmati Nezhad; Mehrdad Bakhshayesh Karam; Alireza Mahdaviani; Leila Mosadegh; Maryam Hassanzad; Seyed Mohsen Mir Hosseini
Journal:  Tanaffos       Date:  2012
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.